FOXM1 and ovarian carcinoma: Given the well-documented role of FOXM1 in cell cycle progression and cellular proliferation, in particular, of ovarian cancer cells [5,13], we next asked whether domatinostat, as an inhibitor of FOXM1 expression, exhibits growth inhibitory effects on ovarian cancer cells.